Selective intracellular delivery of proteasome inhibitors through pH-sensitive polymeric micelles directed to efficient antitumor therapy

Proteasome-inhibitor MG132 conjugated-micelles disintegrate only after cellular internalization through endocytosis in the target cells, where they induce cytotoxic effects and, thus, exert superior anti-tumor efficacy, avoiding systemic toxicity.115